Trial Parameters
Condition Aortic Valve Stenosis
Sponsor Segeberger Kliniken GmbH
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2007-09
Completion 2022-12
Interventions
Transcatheter Aortic Valve Implantation
Brief Summary
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Eligibility Criteria
Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None
Related Trials
NCT03192774
The Prospective Segeberg TAVI Registry
View Trial →
NCT06420830
Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardi
View Trial →
NCT05909748
FIH Study of the GEMINUS TAVI System in Patients With Severe Symptomatic Aortic Stenosis
View Trial →